Early-stage investor Syncona readjusts priorities due to bleak biotech market

The desolate biotech financing environment is starting to take a toll on investment funds, with the UK life sciences firm Syncona announcing it is realigning its priorities. Syncona will look for ways in which existing ...

Jun 20, 2025 - 15:20
 0
Early-stage investor Syncona readjusts priorities due to bleak biotech market
The desolate biotech financing environment is starting to take a toll on investment funds, with the UK life sciences firm Syncona announcing it is realigning its priorities. Syncona will look for ways in which existing ...